Selected Publications

Nasioudis D, Labban N, Gysler S, Ko EM, Giuntoli RL 2nd, Kim SH, Latif NA: Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. Cancers (Basel) 16(11):2051 : 2024.

Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM: Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection. Int J Gynecol Cancer 34(7):969-974 : 2024.

Nasioudis D, Gysler S, Latif N, Cory L, Giuntoli RL 2nd, Kim SH, Simpkins F, Martin L, Ko EM: Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions. Gynecol Oncol 180:1-5 : 2024.

Nasioudis D, Wang X, Dhillon G, Latif N, Ko EM, Giuntoli RL 2nd, Gershenson D, Fader A, Carey M, Simpkins F: Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery. Int J Gynecol Cancer : 33(12):1906-1912,2023.

Nasioudis D, Arevalo O, Gysler S, Ko EM, Cory L, Kim SH, Giuntoli RL 2nd, Latif NA: Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma. Int J Gynecol Cancer ijgc-2023-004805 : 2023.

Nasioudis D, Latif NA, Ko EM, Cory L, Kim SH, Martin L, Simpkins F, Giuntoli R 2nd: Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecol Oncol 177:14-19 : 2023.

Nasioudis D, Labban N, Latif N, Gysler S, Cory L, Kim S, Giuntoli RL 2nd, Ko EM: Role of immunotherapy for lymph node positive vulvar melanoma: utilization and outcomes. Int J Gynecol Cancer 33(9):1347-1353 : 2023.

Wethington SL, Shah PD, Martin L, Tanyi JL, Latif N, Morgan M, Torigian DA, Rodriguez D, Smith SA, Dean E, Domchek SM, Drapkin R, Shih IM, Brown EJ, Hwang WT, Armstrong DK, Gaillard S, Giuntoli R, Simpkins F: Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) trial in acquired PARP-inhibitor-resistant homologous recombination deficient ovarian cancer. Clin Cancer Res 29(15):2800-2807 : 2023.

Nasioudis D, Gysler S, Latif N, Ko E, Cory L, Giuntoli II RL, Kim S, Simpkins F: Molecular profiling of mucinous ovarian carcinoma reveals actionable mutations and a unique genomic profile. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL : 2023.

Nasioudis D, Gysler S, Latif N, Ko E, Cory L, Giuntoli R, Kim S, Simpkins F: Prevalence of ESR1 gene mutations in gynecologic malignancies with high-estrogen receptor expression. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL : 2023.

Academic Contact Information

Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
10th Floor South
Philadelphia, PA 19104
Phone: 800-789-7366
Patient appointments: 800-789-7366